Mookerjee B - Search Results

1

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.

Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gélinas C, Fuchs EJ, Bedi A. Ravi R, et al. Among authors: mookerjee b. Nat Cell Biol. 2001 Apr;3(4):409-16. doi: 10.1038/35070096. Nat Cell Biol. 2001. PMID: 11283615

2

Biological significance and molecular mechanisms of p53-induced apoptosis.

Bedi A, Mookerjee B. Bedi A, et al. Among authors: mookerjee b. Apoptosis. 1998 Sep;3(4):237-44. doi: 10.1023/a:1009648824027. Apoptosis. 1998. PMID: 14646487

3

p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.

Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ, Bedi A. Ravi R, et al. Among authors: mookerjee b. Cancer Res. 1998 Oct 15;58(20):4531-6. Cancer Res. 1998. PMID: 9788595

4

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A. Ravi R, et al. Among authors: mookerjee b. Genes Dev. 2000 Jan 1;14(1):34-44. Genes Dev. 2000. PMID: 10640274 Free PMC article.

5

Overcoming drug resistance: targeting more than one site.

Karp JE, Mookerjee BP. Karp JE, et al. Leuk Res. 2002 Jan;26(1):107-9. doi: 10.1016/s0145-2126(01)00123-0. Leuk Res. 2002. PMID: 11734308 No abstract available.

6

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.

Mookerjee B, Altomonte V, Vogelsang G. Mookerjee B, et al. Bone Marrow Transplant. 1999 Sep;24(5):517-20. doi: 10.1038/sj.bmt.1701936. Bone Marrow Transplant. 1999. PMID: 10482936

7

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.

Rapoport AP, Meisenberg B, Sarkodee-Adoo C, Fassas A, Frankel SR, Mookerjee B, Takebe N, Fenton R, Heyman M, Badros A, Kennedy A, Jacobs M, Hudes R, Ruehle K, Smith R, Kight L, Chambers S, MacFadden M, Cottler-Fox M, Chen T, Phillips G, Tricot G. Rapoport AP, et al. Among authors: mookerjee b. Bone Marrow Transplant. 2002 Feb;29(4):303-12. doi: 10.1038/sj.bmt.1703363. Bone Marrow Transplant. 2002. PMID: 11896427 Free PMC article.

8

Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.

Phillips GL, Meisenberg BR, Reece DE, Adams VR, Badros AZ, Brunner JL, Fenton RG, Filicko J, Grosso DL, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Mookerjee B, Nath R, Rapoport AP, Sarkodee-Adoo C, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Phillips GL, et al. Among authors: mookerjee b. Bone Marrow Transplant. 2004 Apr;33(8):781-7. doi: 10.1038/sj.bmt.1704424. Bone Marrow Transplant. 2004. PMID: 14767498 Clinical Trial.

9

Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir.

Mookerjee BP, Vogelsang G. Mookerjee BP, et al. Bone Marrow Transplant. 1997 Nov;20(10):905-6. doi: 10.1038/sj.bmt.1700988. Bone Marrow Transplant. 1997. PMID: 9404935

10

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.

Hauschild A, Ascierto PA, Schadendorf D, Grob JJ, Ribas A, Kiecker F, Dutriaux C, Demidov LV, Lebbé C, Rutkowski P, Blank CU, Gutzmer R, Millward M, Kefford R, Haas T, D'Amelio A Jr, Gasal E, Mookerjee B, Chapman PB. Hauschild A, et al. Among authors: mookerjee b. Eur J Cancer. 2020 Jan;125:114-120. doi: 10.1016/j.ejca.2019.10.033. Eur J Cancer. 2020. PMID: 31864178 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results